203 related articles for article (PubMed ID: 17119122)
1. TACI regulates IgA production by APRIL in collaboration with HSPG.
Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
[TBL] [Abstract][Full Text] [Related]
2. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
3. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
4. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
5. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
7. APRIL is overexpressed in cancer: link with tumor progression.
Moreaux J; Veyrune JL; De Vos J; Klein B
BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
[TBL] [Abstract][Full Text] [Related]
8. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
[TBL] [Abstract][Full Text] [Related]
9. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
[TBL] [Abstract][Full Text] [Related]
10. APRIL mediates peritoneal B-1 cell homeostasis.
Sindhava VJ; Scholz JL; Stohl W; Cancro MP
Immunol Lett; 2014 Aug; 160(2):120-7. PubMed ID: 24512739
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
Banday VS; Thyagarajan R; Sundström M; Lejon K
Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
[TBL] [Abstract][Full Text] [Related]
13. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
14. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
[TBL] [Abstract][Full Text] [Related]
15. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
Rickert RC; Jellusova J; Miletic AV
Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
[TBL] [Abstract][Full Text] [Related]
16. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.
Guadagnoli M; Kimberley FC; Phan U; Cameron K; Vink PM; Rodermond H; Eldering E; Kater AP; van Eenennaam H; Medema JP
Blood; 2011 Jun; 117(25):6856-65. PubMed ID: 21543761
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
20. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
Hoffmann FS; Kuhn PH; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister HW; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
J Immunol; 2015 Jan; 194(2):542-52. PubMed ID: 25505277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
